Preview

Rational Pharmacotherapy in Cardiology

Advanced search

OBJECTIVE AND SUBJECTIVE FACTORS OF MEDICAL DRUG CHOICE

https://doi.org/10.20996/1819-6446-2017-13-2-197-202

Full Text:

Abstract

Aim. To analyze the factors of medical choice in the prescription of medicinal drug (MD) for the treatment of cardiovascular diseases. Material and methods. A questionnaire survey of 212 doctors (138 physicians and 42 general practitioners) was performed in Irkutsk region and Republic of Buryatia. Questions were related to the physicians’ choice of the original or generic MD and the factors that influence this choice. Results. The majority of respondents prefer the foreign MD, while they prescribed both original and generic drugs (60.4%). The determining factor in the prescription of MD is its efficacy (91.5-95.3%). The main source of information of MD for physicians is the medical literature (78.3%). Only 23.6% of doctors choose the MD based on the results of clinical trials and information about it in specialized medical literature. A half of the respondents believe that their knowledge of cardiovascular MD is insufficient. Doctors need and are interested in information on the pharmacokinetics and pharmacodynamics of MD, side effects, drug interactions and results of clinical studies. Conclusion. It is necessary to focus on the clinical pharmacology of cardiovascular MD during the training of doctors in specialized courses of continuous medical education.

About the Authors

E. B. Babanskaya
Irkutsk State Medical Academy of Postgraduate Education – Branch of Russian Medical Academy of Continuing Professional Education
Russian Federation

Eugene B. Babanskaya - MD, PhD, Assistant, Chair of Family Medicine 

Yubileinyi m/r 100,Irkutsk, 664049




L. V. Menshikova
Irkutsk State Medical Academy of Postgraduate Education – Branch of Russian Medical Academy of Continuing Professional Education
Russian Federation

Larisa V. Menshikova - MD, PhD, Professor, Head of Chair of Family Medicine

Yubileinyi m/r 100,Irkutsk, 664049




References

1. Health care in Russia 2015. Statistical collection of Federal service of the state statistics. Available at: http://www.gks.ru/free_doc/doc_2015/zdrav15.pdf. Accessed by December 12, 2016. (In Russ.) [Здравоохранение в России 2015. Статистический сборник Федеральной служы государственной статистики. Доступно на: http://www.gks.ru/free_doc/doc_2015/zdrav15.pdf. Проверено 12.12.2016].

2. Uvarova J. Market cardiovascular drugs in Russia. Remedium. 2010;4:23-6. (In Russ.) [Уварова Ю. Рынок сердечно-сосудистых препаратов в России. Ремедиум. 2010;4:23-6].

3. WHO Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health. Available at: https://www.whocc.no/atc_ddd_index. Accessed by December 12, 2016.

4. The pharmaceutical market in Russia (October 2016). Available at: http://dsm.ru/docs/analytics/ october_2016_pharmacy_analysis.pdf. Accessed by December 12, 2016. (In Russ.) [Фармацевтический рынок России (Октябрь 2016). Доступно на: http://dsm.ru/docs/analytics/october_ 2016_pharmacy_analysis.pdf. Проверено 2.12.2016].

5. Strategy for medications supply to the population of the Russian Federation up to 2025. Available at: http://www.rosminzdrav.ru/health/guarantee/15. Accessed by December 12, 2016. (In Russ.) [Стратегия лекарственного обеспечения населения Российской Федерации до 2025 года. Доступно на: http://www.rosminzdrav.ru/health/guarantee/15. Проверено 12.12.2016].

6. Menshikova L.V., Kolesnikova E. B. Chronic heart failure (epidemiology, risk factors for development and progression, diagnosis and treatment). Irkutsk: editorial and publishing department Irkutsk State Institute for Medical advanced Studies; 2011. (In Russ.) [Меньшикова Л.В., Колесникова Е.Б. Хроническая сердечная недостаточность (эпидемиология, факторы риска развития и прогрессирования, диагностика и лечение). Иркутск: РИО ИГИУВа; 2011].

7. Martsevich S.Yu., Drozdova L.Yu., Lukina Yu.V., Sinyagina N.V., Kheliya T.G. Evaluation by practicing doctors of the modern pharmacotherapy possibilities in patients with ischemic heart disease. Results of doctor interview in Moscow and Voronezh. Rational Pharmacotherapy in Cardiology. 2010;6(2):1458. (In Russ.) [Марцевич С.Ю., Дроздова Л.Ю., Лукина Ю.В., Синягина Н.В., Хелия Т.Г. Как оценивают практические врачи возможности современной медикаментозной терапии больных хронической ишемической болезнью сердца. Результаты опросов в Москве и Воронеже. Рациональная Фармакотерапия в Кардиологии. 2010;6(2):145-8].

8. Shvets G.I., Povetkin S.V. Pharmacoepidemiological study of doctors habits in prescriptions of antihypertensive drugs in town of Orel. Rational Pharmacotherapy in Cardiology. 2008;1:6-9. (In Russ.) [Швец Г.И., Поветкин С.В. Фармакоэпидемиологические аспекты приверженности врачей лечебно-профилактических учреждений Орла назначению антигипертензивных препаратов. Рациональная Фармакотерапия в Кардиологии. 2008;1:6-9].

9. The study of the attitude of doctors to the issues of drug provision for the population of medical representatives, the draft of the Federal law "About bases of health protection of citizens in Russian Federation". Available at: http://www.epidemiolog.ru/publications/detail.php?ID=246942. Accessed by December 12, 2016. (In Russ.) [Изучение отношения врачей к вопросам лекарственного обеспечения населения, деятельности медицинских представителей, проекту Федерального закона "Об основах охраны здоровья граждан в Российской Федерации". Доступно на: http://www.epidemiolog. ru/publications/detail.php?ID=246942. Проверено 12.12.2016].

10. Belousov Y.B., Leonova M.V., Belousov D.Y., et al. Results of pharmacoepidemiological study of patients with arterial hypertension in Russia (PYTHAGORAS II). Kachestvennaya Klinicheskaya Praktika. 2004;1:17-27. (In Russ.) [Белоусов Ю.Б., Леонова М.В., Белоусов Д.Ю., и др. Результаты фармакоэпидемиологического исследования больных артериальной гипертонией в России (ПИФАГОР II). Качественная Клиническая Практика. 2004;1:17-27].

11. Wazana A. "Physicians and the Pharmaceutical Industry - Is a Gift Ever Just a Gift?" JAMA 2000; 283: 373–0.

12. Barros J.A. (Mis)information on drugs: the double standard practiced by pharmaceutical companies. Cad Saude Pub. 2000;16(2):421-7.

13. Shetty V.V., Karve A.V. Promotional literature: how do we critically appraise? J Postgrad Med. 2008;54(3):217-21.

14. Cardarelli R., Licciardone Jh.C., Taylor L.G. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true? BMC Family Practice. 2006;7:13.

15. Martsevich S.Y., Oganisyan N.S., Dmitrieva N.A., Klimakov A.V. The state of arterial hypertension diagnostics and treatment, according to the results of the poll among physicians of Volgograd and Volgograd region. Rational Pharmacotherapy in Cardiology. 2005;2:32-6. (In Russ.) [Марцевич С.Ю., Оганисян Н.С., Дмитриева Н.А., Климаков А.В. Состояние диагностики и лечения артериальной гипертонии по данным опроса врачей Волгограда и Волгоградской области. Рациональная Фармакотерапия в Кардиологии. 2005;2:32-6].

16. Kheliya T.G., Martsevich S.Yu., Selivanova G.B., et al. Knowledge of modern principles of rational cardiovascular therapy in Moscow primary care physicians: survey-based assessment. Kardiovaskulyarnaya Terapiya i Profilaktika. 2012;11(5):61-6. (In Russ.) [Хелия Т. Г., Марцевич С. Ю., Селиванова Г. Б., и др. Изучение знания современных принципов рациональной фармакотерапии сердечно-сосудистых заболеваний по данным опроса врачей первичного звена здравоохранения города Москвы. Кардиоваскулярная Терапия и Профилактика. 2012; 11(5):61-6].


For citation:


Babanskaya E.B., Menshikova L.V. OBJECTIVE AND SUBJECTIVE FACTORS OF MEDICAL DRUG CHOICE. Rational Pharmacotherapy in Cardiology. 2017;13(2):197-202. (In Russ.) https://doi.org/10.20996/1819-6446-2017-13-2-197-202

Views: 1258


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)